These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 31761118)

  • 1. Risk Reduction in Peanut Immunotherapy.
    Remington BC; Baumert JL
    Immunol Allergy Clin North Am; 2020 Feb; 40(1):187-200. PubMed ID: 31761118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peanut Oral Immunotherapy: State of the Art.
    Tang MLK; Lozinsky AC; Loke P
    Immunol Allergy Clin North Am; 2020 Feb; 40(1):97-110. PubMed ID: 31761124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Food reactions during avoidance: Focus on peanut.
    Capucilli P; Wang KY; Spergel JM
    Ann Allergy Asthma Immunol; 2020 May; 124(5):459-465. PubMed ID: 32001367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions.
    Wasserman RL; Factor JM; Baker JW; Mansfield LE; Katz Y; Hague AR; Paul MM; Sugerman RW; Lee JO; Lester MR; Mendelson LM; Nacshon L; Levy MB; Goldberg MR; Elizur A
    J Allergy Clin Immunol Pract; 2014; 2(1):91-6. PubMed ID: 24565775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peanut allergy and oral immunotherapy.
    Lee TH; Chan JKC; Lau PC; Luk WP; Fung LH
    Hong Kong Med J; 2019 Jun; 25(3):228-234. PubMed ID: 31178442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severity and threshold of peanut reactivity during hospital-based open oral food challenges: An international multicenter survey.
    Arkwright PD; MacMahon J; Koplin J; Rajput S; Cross S; Fitzsimons R; Davidson N; Deshpande V; Rao N; Lumsden C; Lacy D; Allen KJ; Vance G; Mwenechanya J; Fox AT; Erlewyn-Lajeunesse M; Mistry H; Hourihane JO
    Pediatr Allergy Immunol; 2018 Nov; 29(7):754-761. PubMed ID: 30022517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Economic Analysis of a Peanut Oral Immunotherapy Study in Children.
    Shaker MS
    J Allergy Clin Immunol Pract; 2017; 5(6):1707-1716. PubMed ID: 28606784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current opinion and review on peanut oral immunotherapy.
    Deol S; Bird JA
    Hum Vaccin Immunother; 2014; 10(10):3017-21. PubMed ID: 25483680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Trend in Immunotherapy for Peanut Allergy.
    Joo Chan C; Richardo T; Lim RLH
    Int Rev Immunol; 2018; 37(6):279-290. PubMed ID: 30638084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on the controversy around offering oral immunotherapy to peanut-allergic children outside of research.
    Soller L; Abrams EM; Chan ES
    Ann Allergy Asthma Immunol; 2019 Jun; 122(6):559-562. PubMed ID: 30794857
    [No Abstract]   [Full Text] [Related]  

  • 11. Peanut Allergy: New Advances and Ongoing Controversies.
    Abrams EM; Chan ES; Sicherer S
    Pediatrics; 2020 May; 145(5):. PubMed ID: 32303583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current perspectives on peanut allergy.
    Frith K; Katelaris CH
    Intern Med J; 2019 Dec; 49(12):1480-1487. PubMed ID: 31808255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative risk reduction through peanut immunotherapy: Safety benefits of an increased threshold in Europe.
    Remington BC; Krone T; Koppelman SJ
    Pediatr Allergy Immunol; 2018 Nov; 29(7):762-772. PubMed ID: 30054934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peanut allergen powder (Palforzia).
    Med Lett Drugs Ther; 2020 Mar; 62(1593):33-34. PubMed ID: 32555119
    [No Abstract]   [Full Text] [Related]  

  • 15. Towards immunotherapy for peanut allergy.
    Pons L; Palmer K; Burks W
    Curr Opin Allergy Clin Immunol; 2005 Dec; 5(6):558-62. PubMed ID: 16264338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peanut Oral Immunotherapy: a Current Perspective.
    Patrawala M; Shih J; Lee G; Vickery B
    Curr Allergy Asthma Rep; 2020 Apr; 20(5):14. PubMed ID: 32314071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epicutaneous immunotherapy for peanut allergy modifies IgG
    Koppelman SJ; Peillon A; Agbotounou W; Sampson HA; Martin L
    J Allergy Clin Immunol; 2019 Mar; 143(3):1218-1221.e4. PubMed ID: 30389411
    [No Abstract]   [Full Text] [Related]  

  • 18. Peanut-allergic patient experiences after epicutaneous immunotherapy: peanut consumption and impact on QoL.
    Lewis MO; Brown-Whitehorn TF; Cianferoni A; Rooney C; Spergel JM
    Ann Allergy Asthma Immunol; 2019 Jul; 123(1):101-103. PubMed ID: 30978404
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunotherapy approaches for peanut allergy.
    Kim EH; Patel C; Burks AW
    Expert Rev Clin Immunol; 2020 Feb; 16(2):167-174. PubMed ID: 31928251
    [No Abstract]   [Full Text] [Related]  

  • 20. Peanut Allergen Powder (Palforzia) for Peanut Allergy.
    Erlich D
    Am Fam Physician; 2022 Jan; 105(1):20-21. PubMed ID: 35029941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.